RLS-1496 topical cream

RLS-1496 · Rubedo Life Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RLS-1496 topical cream, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate RLS-1496 Topical Cream for Actinic Keratosis [Phase 1, Phase 2]